Psychophysiological mechanisms in panic disorder: A correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability, and psychological variables

Psychosomatic Medicine

Volumn 68, Issue 1, 2006, Pages 8-16

  Alvarenga, Marlies E ^a,b   Richards, Jeffrey C ^a   Lambert, Gavin ^b   Esler, Murray D ^b  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Heart disease; Heart rate variability; Neuronal reuptake mechanism; Noradrenaline spillover; Panic disorder; Sympathetic nervous system function

Indexed keywords

ADRENALIN; NORADRENALIN; NORADRENALIN TRANSPORTER;

ADRENERGIC SYSTEM; ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART DISEASE; HEART RATE VARIABILITY; HUMAN; MALE; NORADRENALIN RELEASE; PANIC; PLASMA CLEARANCE; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOPHYSIOLOGY; SENSITIZATION; STATE TRAIT ANXIETY INVENTORY; SYMPATHETIC TONE; VAGUS NERVE STIMULATION;

EID: 33744497807     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000195872.00987.db     Document Type: Article

References (53)

1. Beitman BD, Mukerji V, Lamberti JW, Schmid L, Kushner M. Major depression and agoraphobia in patients with angiographically normal coronary arteries and panic disorder. Can J Psychiatry 1990;35:298-304.
2. Mansour VM, Wilkinson DJC, Jennings GL, Schwarz RG, Thompson JM, Esler MD. Panic disorder: coronary spasm as a basis for cardiac risk? Med J Australia 1998;168:390-2.
3. Fleet R, Lavoie K, Beitman BD. Is panic disorder associated with coronary artery disease? a critical review of the literature. J Psychosom Res 2000;48:347-56.
4. Coryell W, Noyes R, House D Mortality among outpatients with anxiety disorders. Am J Psychiatry 1986;143:508-10.
5. Kawachi I, Colditz GA, Asherio A, Rimm EB, Giovannucci E, Stampfer MJ, Willet WC. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation, 1994;89:1992-7.
6. Esler MD. Mental stress, panic disorder and the heart. Stress Med 1998;14:237-43.
7. Goldstein DS, Robertson D, Esler M, Strauss SE. Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med 2002;137:753-63.
8. Malik M, Camm AJ, eds. Heart Rate Variability. Armonk, NY: Futura; 1995.
9. Yeragani VK, Pohl R, Berger R, Balon R, Ramesh C, Glitz D, Srinivasan K, Weinberg P. Decreased heart rate variability in panic disorder patients: a study of power spectral analyses of heart rate. Psychiatry Res 1993:46;89-103.
10. Middleton HC, Ashby M. Clinical recovery from panic disorder is associated with evidence of changes in cardiovascular regulation. Acta Psychiatr Scand 1995;91:108-13.
11. Gorman JM, Sloan RP. Heart rate variability in depressive and anxiety disorders. Am Heart J 2000;140:77-83.
12. Umetani K, Singer DH, McCraty R, Atkinson M. Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J Am Coll Cardiol 1998;31:593-601.
13. Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence for a selective increase in resting cardiac sympathetic activity in some patients suffering sustained out of hospital ventricular arrhythmias. N Engl J Med 1991;325:618-24.
14. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995;26:1257-63.
15. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med 1996;334:413-9.
16. Esler M, Lambert G, Jennings G. Measurement of overall and cardiac norepinephrine release into plasma during cognitive challenge. Psychoneuroendocrinology 1989;14:477-81.
17. Wilkinson DJC, Thompson JM, Lambert GW, Jennings GL, Schwarz RG, Jeffreys D, Turner AG, Esler MD. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch Gen Psychiatry 1998;55:51-2.
18. Axselrod S, Gordon D, Madwed JB, Snidman NC, Shannon DC, Cohen RJ. Hemodynamic regulation: investigation by spectral analysis. Am J Physiol Heart Circ 1985;249:H867-75.
19. Kingwell BA, Thompson JM, Kaye D M, McPherson GA, Jennings GL, Esler MD. Congestive heart failure/hypertension/hypertrophy: heart rate spectral analysis, cardiac norephinephrine spillover and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994;90:234-40.
20. Eckberg DL. Spectral balance: a critical appraisal. Circulation 1997;96:3224-32.
21. Yeragani VK, Pohl R, Balon R, Ramesh C, Glitz D, Sherwood P. Risk factors for cardiovascular illness in panic disorder patients. Neuropsychobiology 1990;23:134-9.
22. Friedman BH, Thayer JF. Autonomic balance revisited: panic anxiety and heart rate variability. J Psychosom Res 1998;44:133-51.
23. Reiss S, McNally RJ. The expectancy model of fear. In: Reiss S, Bootzin RR, eds. Theoretical issues in behaviour therapy. New York: Academic Press: 1985:107-21.
24. Reiss S. Expectancy model of fear, anxiety, and panic: clinical psychology review: special issue: applied learning theory: research issues for the 1990s. 1991;11:141-53.
25. Brown TA, DiNardo PA, Barlow DH. Anxiety Disorders Interview Schedule for DSM-IV (Adult Version). San Antonio, TX: Graywind Publications: 1994.
26. Taylor S, Cox BJ. An expanded anxiety sensitivity index: evidence for a hierarchic structure in a clinical sample. J Anxiety Disord 1998;12:463-83.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Text Edition-Revised. Washington, DC: APA; 2000.
28. Spielberger CD. State-Trait Anger Expression Inventory (STAXI). Florida: Psychologic Assessment Resources; 1991.
29. Jacobs GA, Latham LE, Brown MS. Test re-test reliability of the State-Trait Personality Inventory and the Anger Expression Scale. Anxiety Res 1988:1:263-5.
30. Esler M, Jennings G, Biviano B, Lambert G, Haskin G. Measurement of total and organ specific norepinephrine kinetics in humans. Am J Physiol 1984;247:E21-8.
31. Esler MD, Jennings G, Lambert G, Meredith I, Horne M, Einsenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 1990;70:963-85.
32. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS, Esler MD. Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996;93:1667-76.
33. Esler M, Jackman G, Bobik A, Kelleher D, Jennings G, Leonard P, Skews H, Korner P. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci 1979;25:1461-70.
34. Medvedev OS, Esler MD, Angus JA, Cox HS, Eisenhofer G. Simultaneous determination plasma noradrenaline and adrenaline kinetics: responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit. Naunyn Schmiedebergs Arch Pharmacol 1990;341:192-9.
35. Goldstein DS, Brush JE, Einsenhofer G, Stull R, Esler M. In vivo measurement of neuronal uptake of norepinephrine in the human heart. Circulation 1988;78:41-8.
36. Meredith IT, Esler MD, Cox HS, Lambert GW, Jennings GL, Eisenhofer G. Biochemical evidence of sympathetic denervation of the heart in pure autonomie failure. Clin Auton Res 1991;1:187-94.
37. Gravetter FJ, Wallnau LB. Statistics for the Behavioral Sciences: A First Course for Students of Psychology and Education. 3rd ed. New York: West Publishing Co; 1992.
38. Cameron OG, Lee MA, Curtis GC, McCann DS. Endocrine and physiological changes during "spontaneous" panic attacks. Psychoneuroendocrinology 1987;12:321-31.
39. Margraf J, Taylor B, Ehlers A, Roth WT, Agras WS. Panic attacks in the natural environment. J Nerv Ment Dis 1987;175:558-65.
40. Yeragani VK, Sobolewski E, Igel G, Johnson C, Jampala VC, Kay J, Hillman N, Yeragani S, Venpati S. Decreased heart-period variability in patients with panic disorder: a study of Holter ECG records. Psychiatry Res 1998;78:89-99.
41. Grassi M, Esler M. How to assess sympathetic activity in humans. J Hypertens 1999;17:719-34.
42. Virtanen R, Jula A, Salminen JK, Voipio-Pulkki LM, Helenius H, Kuusela T, Airaksinen J. Anxiety and hostility are associated with reduced baroreflex sensitivity and increased beat-to-beat blood pressure variability. Psychosom Med 2003;65:751-6.
43. Lambert EA, Thompson J, Schlaich M, Laude D, Elghozi JL, Esler MD, Lambert GW. Sympathetic and cardiac baroreflex function in panic disorder. J Hypertens 2002;20:2445-51.
44. Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD. Effect of sunlight and season on serotonin turnover in the brain. Lancet 2002;360:1840-2.
45. Lambert EA, Thompson J, Schlaich M, Laude D, Elghozi J-L, Esler MD, Lambert GW. Sympathetic and cardiac baroreflex function in panic disorder. J Hypertens 2002;20:1-7.
46. Lessmeier TJ, Gamperling D, Johnson-Liddon V, Fromm BS, Steinmann RT, Meissner MD, Lehmann MH. Unrecognized paroxysmal supraventricular tachycardia. Arch Intern Med 1997;157:537-43.
47. Godemann F, Ahrens B, Behrens S, Berthold R, Gandor C, Lampe F, Linden M. Classical conditioning and dysfunctional cognitions in patients with panic disorder and agoraphobia treated with an implantable cardioverter defibrillator. Psychosom Med 2001;63:231-8.
48. Rumantir MS, Kaye DM, Jennings GL, Vaz M, Hastings JA, Esler MD. Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension 2000;36:824-9.
49. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 2000;342:541-9.
50. Davies SJ, Ghahramani P, Jackson PR, Noble TW, Hardy PG, Hippislet-Cox J, Yeo WW, Ramsay LE. Association of panic disorder and panic attacks with hypertension. Am J Med 1999;107:310-6.
51. Stemmler G, Heldmann M, Pauls CA, Schemer T. Constraints for emotion specificity in fear and anger: the context counts. Psychophysiology 2001;38:275-91.
52. Gerra G, Garofano L, Bosari S, Pellegrini C, Zaimovic A, Moi G, Bussandri M, Moi A, Brambilla F, Mameli A, Pizzamiglio M, Donnini C. Analysis of monoamine oxidase A (MAO-A) promoter polymorphism in male heroin-dependent subjects: behavioural and personality correlates. J Neural Transm 2004;111:611-21.
53. Stalenheim EG. Long-term validity of biological markers of psychopathy and criminal recidivism: follow-up 6-8 years after forensic psychiatric investigation. Psychiatry Res 2004;121:281-91.